Robert A Anders Selected Research

Transcription Factors (Transcription Factor)

1/2023	Detecting Liver Cancer Using Cell-Free DNA Fragmentomes.
7/2017	Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy.
1/2015	The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
1/2014	Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection.
3/2013	Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
3/2012	Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma.
4/2009	The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Anders Research Topics

Disease

86	Neoplasms (Cancer) 04/2024 - 01/2006
18	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 05/2010
13	Adenocarcinoma 02/2024 - 04/2011
13	Carcinogenesis 11/2022 - 03/2003
12	Melanoma (Melanoma, Malignant) 03/2024 - 03/2012
12	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2012
10	Inflammation (Inflammations) 03/2024 - 03/2004
9	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 04/2009
7	Fibrosis (Cirrhosis) 01/2022 - 03/2003
5	Liver Neoplasms (Liver Cancer) 01/2023 - 09/2012
5	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2011
5	Cholangiocarcinoma 01/2022 - 09/2012
5	Liver Diseases (Liver Disease) 11/2021 - 09/2011
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 03/2004
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 06/2012
3	Weight Gain 12/2023 - 10/2018
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 06/2012
3	Infections 01/2018 - 01/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 01/2013
3	Hepatomegaly 06/2012 - 07/2005
2	Stomach Ulcer (Gastric Ulcer) 12/2023 - 10/2018
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 02/2023 - 01/2018
2	Autoimmune Hepatitis 02/2023 - 01/2022
2	Alcoholic Hepatitis 02/2023 - 01/2018
2	Weight Loss (Weight Reduction) 01/2022 - 01/2022
2	End Stage Liver Disease 01/2022 - 01/2018
2	Myocarditis (Carditis) 10/2021 - 11/2016
2	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 05/2012
2	Microsatellite Instability 12/2019 - 10/2019
2	Merkel Cell Carcinoma 10/2018 - 07/2013
2	Carcinoma (Carcinomatosis) 09/2017 - 06/2015
2	Turcot syndrome 01/2017 - 06/2015
2	Circulating Neoplastic Cells 12/2016 - 10/2016
2	Cholestasis 12/2016 - 05/2014
2	Hypoxia (Hypoxemia) 10/2015 - 04/2009
2	Body Weight (Weight, Body) 06/2015 - 06/2012
1	Breast Neoplasms (Breast Cancer) 02/2024

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 10/2023 - 11/2008
17	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2013
16	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2016
11	NivolumabIBA 02/2024 - 01/2013
8	B7-H1 AntigenIBA 04/2024 - 01/2017
8	AntigensIBA 03/2024 - 03/2005
8	LigandsIBA 12/2021 - 03/2004
7	AntibodiesIBA 02/2023 - 04/2011
7	Transcription Factors (Transcription Factor)IBA 01/2023 - 04/2009
7	CytokinesIBA 01/2018 - 03/2005
6	VaccinesIBA 01/2021 - 01/2015
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2015
6	ParaffinIBA 01/2020 - 01/2013
5	Formaldehyde (Formol)FDA Link 01/2020 - 01/2016
4	IpilimumabIBA 02/2024 - 11/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2009
4	pembrolizumabIBA 01/2020 - 06/2015
4	EnzymesIBA 01/2019 - 04/2009
3	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 03/2012
3	Tumor Biomarkers (Tumor Markers)IBA 12/2019 - 10/2016
3	Annexin A2 (Annexin II)IBA 01/2019 - 04/2011
3	InterferonsIBA 07/2017 - 03/2012
3	Phosphotransferases (Kinase)IBA 12/2015 - 01/2006
3	Lymphotoxin beta ReceptorIBA 05/2007 - 03/2004
2	entinostat (MS 275)IBA 02/2024 - 11/2021
2	Hormones (Hormone)IBA 02/2024 - 09/2020
2	GhrelinIBA 12/2023 - 10/2018
2	Immunoglobulin A (IgA)IBA 02/2023 - 03/2004
2	cabozantinibIBA 01/2023 - 01/2023
2	Cell-Free Nucleic AcidsIBA 01/2023 - 12/2019
2	ChromatinIBA 01/2023 - 09/2017
2	Small Interfering RNA (siRNA)IBA 11/2022 - 04/2011
2	MucinsIBA 01/2022 - 10/2019
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2021 - 07/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 01/2020
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2016
2	Nonmuscle Myosin Type IIBIBA 01/2019 - 02/2015
2	Nonmuscle Myosin Type IIAIBA 01/2019 - 02/2015
2	Protein Isoforms (Isoforms)IBA 01/2018 - 08/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2014
2	Complement System Proteins (Complement)IBA 01/2018 - 05/2009
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2017 - 01/2014
2	Messenger RNA (mRNA)IBA 11/2016 - 07/2011
2	CTLA-4 AntigenIBA 01/2016 - 01/2015
2	PolyphenolsIBA 12/2015 - 09/2011
2	CurcuminIBA 12/2015 - 09/2011
2	Semaphorins (Semaphorin)IBA 08/2015 - 03/2003
2	Neurofibromin 2 (Merlin)IBA 06/2012 - 07/2010
2	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2005 - 06/2005
2	Glycoproteins (Glycoprotein)IBA 07/2005 - 06/2005
2	Caveolin 1IBA 03/2004 - 03/2003
1	Dinoprostone (PGE2)FDA Link 03/2024
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 03/2024

Therapy/Procedure

40	Therapeutics 04/2024 - 08/2010
21	Immunotherapy 10/2023 - 01/2013
9	Liver Transplantation 01/2022 - 05/2009
5	Radiotherapy 02/2024 - 01/2016
4	Microspheres (Microsphere) 12/2023 - 10/2018
4	Drug Therapy (Chemotherapy) 10/2023 - 11/2017
3	Neoadjuvant Therapy 10/2023 - 01/2022
3	Transplantation 01/2018 - 03/2007
3	Castration 01/2018 - 06/2012
2	Aftercare (After-Treatment) 11/2016 - 01/2015